Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Degradation of Top2b and Top2a in Human by Dexrazoxane × Dexrazoxane × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia 1 Heart Failure 1 Ganglioneuroblastoma 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Cardiotoxicity 1 Burkitt Lymphoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡